The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant attention within the United Kingdom , prompting a notable shift in hormone trends. Obtaining these treatments remains a complex landscape, with NHS approval currently limited and private clinics offering prescriptions at a premium . Questions are being raise